COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 273: Articles 2721-2730  | Next

Assessment of the impact of the Vaccine Pass Policy on COVID-19 vaccine hesitancy and uptake among Chinese adults in Hong Kong
Wong, I. O. L., Wong, C., Mak, N., Dai, A., Xiao, J., Wu, P., Ni, M. Y., Liao, Q., Cowling, B. J.
10.1101/2023.12.03.23299354 — Posted: 2023-12-04
Identification of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir
Krismer, L., Schoeppe, H., Rauch, S., Bante, D., Sprenger, B., Naschberger, A., Costacurta, F., Fuerst, A., Sauerwein, A., Rupp, B., Kaserer, T., von Laer, D., Heilmann, E.
10.1101/2023.12.04.569917 — Posted: 2023-12-04
Sex-Specific Systemic Inflammatory Responses in Mice Infected with a SARS-CoV-2-like Virus and Femur Fracture
Patrick, M. D., Foster, A., Aneja, A., Annamalai, R. T.
10.1101/2023.12.04.567060 — Posted: 2023-12-04
Design of SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
Tan, B., Zhang, X., Ansari, A., Jadhav, P., Tan, H., Li, K., Chopra, A., Ford, A., Chi, X., Figueras, F. R., Arnold, E., Deng, X., Wang, J.
10.1101/2023.12.01.569653 — Posted: 2023-12-03
Memory B cells dominate the early antibody-secreting cell response to SARS-CoV-2 mRNA vaccination in naive individuals independently of their antibody affinity
Li, Z., Obraztsova, A., Shang, F., Oludada, O. E., Malapit, J., Busch, K., van Straaten, M., Stebbins, E., Murugan, R., Wardemann, H.
10.1101/2023.12.01.569639 — Posted: 2023-12-03
Substrate recognition and selectivity in SARS-CoV-2 main protease: Unveiling the role of subsite interactions through dynamical nonequilibrium molecular dynamics simulations
Chan, H. T. H., Oliveira, A. S. F., Mulholland, A. J., Schofield, C. J., Duarte, F.
10.1101/2023.12.01.569046 — Posted: 2023-12-03
Connecting the Dots: Systematic Exploration of COVID-19 and Acute Kidney Injury through Meta-Analysis
Sarker, M. S., Jahan, R.
10.1101/2023.12.01.23299310 — Posted: 2023-12-02
High-throughput ML-guided design of diverse single-domain antibodies against SARS-CoV-2
Angermueller, C., Marie, Z., Jester, B., Engelhart, E., Emerson, R., Alipanahi, B., McCaw, Z. R., Roberts, J., Lopez, R. M., Younger, D., Colwell, L.
10.1101/2023.12.01.569227 — Posted: 2023-12-01
Population age as a key factor in the COVID-19 pandemic dynamics
Nesteruk, I., Keeling, M.
10.1101/2023.11.30.23299229 — Posted: 2023-12-01
Knowledge mobilisation of rapid evidence reviews to inform health and social care policy and practice in a public health emergency: appraisal of the Wales COVID-19 Evidence Centre processes and impact, 2021-23.
Gal, M., Cooper, A., Joseph-Williams, N., Doe, E. C., Lewis, R., Law, R.-J., Anstey, S., Davies, N., Walters, A., Orford, R., Collins, B., Trigg, L., Roberts, C., Meredith, S., Macey, S., Carson-Stevens, A. P., Greenwell, J., Coomber, F., Edwards, A. G.
10.1101/2023.11.30.23299238 — Posted: 2023-12-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).